期刊文献+

前列腺癌中HIF-1α和COX-2的表达及与血管生成的关系 被引量:2

Expression of HIF-1α and COX-2 in prostate cancer and its relationship with angiogenesis
暂未订购
导出
摘要 目的探讨缺氧诱导因子-1α(HIF-1α)和环氧合酶-2(COX-2)在前列腺癌组织中的表达情况及与肿瘤血管形成的关系。方法应用免疫组化(SP)法检测72例不同病理级别前列腺癌组织中HIF-1α、COX-2的表达,用八因子相关抗原(VIII-R-Ag)标记微血管密度(MVD)。结果HIF-1α、COX-2在不同病理级别前列腺癌中表达差异有统计学意义;HIF-1α、COX-2与前列腺癌病理分级存在显著相关性;MVD在不同病理级别前列腺癌组织中差异有统计学意义;HIF-1α、COX-2的表达与MVD存在显著相关性,HIF-1α与COX-2的表达呈正相关。结论HIF-1α和COX-2与前列腺癌的恶性程度有关,并可能在促进肿瘤血管形成过程中起协同作用。 Objective To study the expression of HIF-1αand COX-2 in prostate cancer and its relationship with tumor angiogenesis.Methods The expression of HIF-1αand COX-2 was examined by immunohistochemistry Streptavidin-Peroxidase(SP)method in 72 cases of prostatic carcinoma with different pathological grades,and the MVD was marked out by the VIII-R-Ag.Results There was a statistically significance in the expression differences of HIF-1αand COX-2 in prostatic carcinoma with different pathological grades;significant correlation was showed between HIF-1αand COX-2 and the pathological grading of prostate cancer;the differences of MVD in prostate cancer with different grades hade a statistically significance;the expression of HIF-1αand COX-2 had a significant correlation with MVD,and positive correlation was showed in the expression of HIF-1αand COX-2.Conclusion HIF-1αand COX-2 relate to malignancy of prostate cancer,and have a synergistic effect in tumor angiogenesis process.
出处 《医学研究与教育》 CAS 2012年第5期18-22,共5页 Medical Research and Education
关键词 前列腺癌 HIF-1Α COX-2 MVD 免疫组化 血管生成 prostate cancer HIF-1α COX-2 MVD immunohistochemistry streptavidin-peroxidase angiogenesis
  • 相关文献

参考文献11

  • 1POWIS G, KIRKPATRICK L.Hypoxia inducible factor-1 alpha as acancer drug target[J]. Mol CancerTher, 2004, 3(5): 647-654.
  • 2QIU M Z, HAN B, LUO H Y, et al. Expressions of hypoxia-inducible factor-1α and hexokinase-Ⅱ in gastric adenocarcinoma: the impact on prognosis and correlation to clinicopathologic features[J]. Tumour Biol, 2011, 32(1): 159-166.
  • 3PISTOLLATO F, RAMPAZZO E, PERSANO L, et al. Interaction of hypoxia-inducible factor- 1α and Notch signaling regulates medulloblastoma precursor proliferaition and fate[J]. Stem Cells, 2010, 28(11): 1918-1929.
  • 4KONG HS, LEE S, BEEBE K, et al. Emetime promotes von Hippel-Lindau-independent degradation of hypoxia inducible factor-2α in clear cell renal carcinoma[J]. Mol Pharmacol, 2010, 78(6): 1072-1078.
  • 5平浩,陈晓春,王辉,陈朝晖,曾甫清,鲁功成.缺氧诱导因子-1α在前列腺癌中的表达及意义[J].中华泌尿外科杂志,2004,25(2):88-90. 被引量:10
  • 6LIU Y, CHRISTOU H, MORITA T, et al.Carbon monoxide and nitrc oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5 'enhancer[J]. J Biol Chem, 1998, 273(24):15257-15262.
  • 7XU X C. COX-2 inhibitors in cancer treatm ent and prevention, arecent development [J]. Anticaneer Drugs, 2002, 13(2): 127.
  • 8YAO M, KARGMAN S, LAME C, et al. Inhibition of cyclooxygerrase 2 by rofecoxib attenes the growth and metastic poterrtial of colorectal car einoma in mice[J]. Cancer Research, 2003, 63(3): 586.
  • 9ABIRU S, NAKAO K, ICHIKAWA T, et al. Aspirin and NS398 irrhibit bepatocyte growth factorinduccd in vasivenes of hu man hepatoma cella[J]. Hepatology, 2002, 35(5): 1117.
  • 10LIN X H, KINSCHENBAUM A, LU M, et al. Prostaglandin E2induces hypoia-inducible factor I a stabilization and nuclear localization in a human prostate cancer cell line[J]. J Biol Chem, 2002, 277(51): 50081.

二级参考文献19

  • 1Semenza GL.Targeting HIF-1 for cancer therapy[J].Nat Rev Cancer,2003,3(10):721.
  • 2Blancher C,Moore JW,Talks KL,et al.Relationship of hypoxia-inducible factor(HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines[J].Cancer Res,2000,60(24):710.
  • 3Xu XC.COX-2 inhibitors in cancer treatment and prevention,a recent development[J].Anticancer Drugs,2002.13(2):127.
  • 4Huang SP,Wu MS,Shun CT,et al.Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma[J].J Biomed Sci,2005,12(1):229.
  • 5Bae SH,Jung ES,Park YM,et al.Expression of cyclooxygenase-2(COX-2)in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor,NS-398[J].Clin Cancer Res,2001,7(5):1410.
  • 6Fosslien E.Review:molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis[J].Ann Clin Lab Sci,2001,31(4):325.
  • 7Gallo O,Eranchi A,Magnelli L,et al.Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer.Implications for tumor angiogenesis and metastasis[J].Neoplasia,2001,3(1):53.
  • 8Leahy KM,Koki AT,Masferrer JL.Role of cyclooxygenases in angiogenesis[J].Curr Med Chem,2000,7(11):1163.
  • 9Yao M,Kargman S,Lam EC,et al.Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice[J].Cancer Research,2003,53(3):586.
  • 10Abiru S,Nakao K,Ichikawa T,et al.Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells[J].Hepatology,2002,35(5):1117.

共引文献14

同被引文献50

  • 1吴珏堃,唐勇,邱万寿.SIAH2在乳腺癌及癌旁组织中的差异表达及其临床意义[J].岭南现代临床外科,2012,12(6):403-406. 被引量:4
  • 2Georgieva M,Krasteva M,Angelova E. Analysis of the K-ras/B-raf/Erk signal cascade,p53 and CMAP as markers for tumor progression in colorectal cancer patients[J].{H}Oncology Reports,2008,(01):3-11.
  • 3Reed J C,Ely K R. Degrading liaisons:Siah structure revealed[J].{H}Natural Structural Biology,2002,(01):8-10.
  • 4Miyazawa M,Yasuda M,Fujita M. Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma[J].{H}Pathology International,2009,(01):19-27.
  • 5Wong CC,Zhang H,Gilkes DM. Inhibitors of hypoxiainducible factor 1 block breast cancer metastatic niche formation and lung metastasis[J].J Mol Med (Berl),2012,(07):803-815.
  • 6Adams JM,Difazio LT,Rolandelli RH. HIF-1:a key mediator in hypoxia[J].{H}ACTA PHYSIOLOGICA HUNGARICA,2009,(01):19-28.
  • 7Semenza GL. Hypoxia-inducible factors:mediators of cancer progression and targets for cancer therapy[J].{H}TRENDS IN PHARMACOLOGICAL SCIENCES,2012,(04):207-214.
  • 8Koh MY,Spivak-Kroizman TR,Powis G. HIF-1alpha and cancer therapy[J].{H}Recent Results in Cancer Research,2010.15-34.
  • 9Winder T,Mundlein A,Rhomberg S. Different types of K-Ras mutations are conversely associated with overall survival in patients with colorectal cancer[J].{H}Oncology Reports,2009,(05):1283-1287.
  • 10Kim SK,Novak RF. The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression[J].{H}Pharmacology & Therapeutics,2007,(01):88-120.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部